Discontinuation of biologic therapy in severe asthma: Evidence and strategies for safe withdrawal: A scoping review

Introduction: Severe asthma is characterized by poor disease control despite the use of high-dose inhaled corticosteroids and long-acting bronchodilators. Biologic therapies have revolutionized its management, allowing some patients to achieve remission. However, uncertainty remains regarding the op...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Johanna Ramirez-Villamizar, MD, Ciro D. Ibarra-Enríquez, MD, Juan Sebastián Galindo-Sánchez, MD, Carlos Serrano-Reyes, MD, Liliana Fernández-Trujillo, MD
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2025-09-01
Ráidu:	World Allergy Organization Journal
Fáttát:	Severe asthma Biologic therapy Discontinuation Withdrawal Scoping review
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S1939455125000845
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!